Dr. Charles Steven Schramm, MD

Dr. Schramm practices at The Hand & Upper Extremity Surgery Center of Georgia in Atlanta, Georgia.

Dr. Schramm's NPI, 1447205661, was assigned on May 24, 2006. Dr. Schramm holds Georgia license 029944.

Dr. Schramm's primary practice is The Hand & Upper Extremity Surgery Center of Georgia, at 993d Johnson Ferry Road, Suite 200, Atlanta, GA 30342. The practice phone is (404) 969-1996. Dr. Schramm also practices at The Hand and Upper Extremity Surgery Center of Georgia, LLC, 993 Johnson Ferry NE Rd, Atlanta, GA 30342.

Dr. Schramm's primary practice is The Hand & Upper Extremity Surgery Center of Georgia in Atlanta, Georgia. Dr. Schramm is also affiliated with Northside Hospital Atlanta. The medical group on file is Family Practice Center, PC. Dmand AI also links Dr. Schramm to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schramm practices, 6 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Schramm's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Schramm is licensed in Georgia.

CMS data shows 1,741 Medicare services from Dr. Schramm across 24 procedure codes in 2024, for 288 Medicare patients. Medicare paid $93,450 for them. Every service was in an office.

CMS counts 288 Medicare patients who saw Dr. Schramm in 2024. The largest group is 65 to 74, with 186 patients. 68% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schramm's median patient age at 54, with 46% women.

In 2024, Dr. Schramm wrote 3,781 Medicare Part D claims for 392 patients. 87% of them were for generic drugs. CMS names the drug for 3,038 of them, across 94 drugs with 11 or more claims each, at $230,441 in total drug cost. In 2023, CMS named 3,082 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Schramm for performance year 2024, reported through an alternative payment model (APM). Dr. Schramm accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schramm as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,243 general payments to Dr. Schramm from 86 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,998.